Physician profile
Robert S Wright
NPI 1962498550
$17,274.72
in general payments reported to CMS, 2019-2025
44 companies · $2,731 in 2025
The $2,731 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,883 · 2020: $1,095 · 2021: $1,891 · 2022: $1,956 · 2023: $4,803 · 2024: $2,916 · 2025: $2,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,926 · Travel and Lodging: $1,374 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,925.65 |
| Travel and Lodging | $1,373.94 |
| Education | $150.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,990.13 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Pulmonx Corporation | $2,146.30 | 2022-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Astrazeneca Pharmaceuticals Lp | $1,740.35 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,509.58 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $1,252.77 | 2020-2025 | Dupixent |
| Insmed, INC. | $736.49 | 2019-2025 | Arikayce, Brinsupri |
| Olympus Corporation of The Americas | $666.99 | 2019 | |
| Grifols USA, LLC | $635.97 | 2021-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $631.93 | 2023-2025 | Tyvaso, Tyvaso, Remodulin |
| Paratek Pharmaceuticals, INC. | $547.70 | 2020-2025 | Nuzyra |
| Electromed, INC. | $452.11 | 2021-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $437.93 | 2019-2025 | |
| Genzyme Corporation | $362.98 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $329.53 | 2019-2025 | Winrevair, Recarbrio, Zerbaxa |
| Shionogi INC | $316.68 | 2021-2025 | Fetroja |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $304.25 | 2021-2025 | Avycaz |
| Actelion Pharmaceuticals US, INC. | $249.44 | 2019-2025 | Uptravi |
| Baxter Healthcare | $247.92 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Bayer Healthcare Pharmaceuticals INC. | $158.17 | 2023-2025 | |
| Mylan Specialty L.P. | $154.62 | 2021-2024 | Yupelri |
| Amgen INC. | $142.59 | 2022-2025 | Tezspire |
| Verona Pharma, INC. | $141.76 | 2025 | Ohtuvayre |
| Allergan, INC. | $128.71 | 2019-2020 | |
| Advanced Respiratory, INC | $122.64 | 2019-2021 | |
| La Jolla Pharmaceutical Company | $104.60 | 2023-2025 | Giapreza |
| Pfizer INC. | $103.40 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $79.73 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $77.51 | 2019-2020 | |
| Philips North America LLC | $63.43 | 2021-2025 | Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $59.97 | 2023-2025 | Glassia |
| Viatris Specialty LLC | $58.64 | 2025 | Yupelri |
| Inari Medical, INC. | $41.13 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech USA, INC. | $37.58 | 2019 | |
| Chiesi USA, INC. | $34.26 | 2020 | |
| Nabriva Therapeutics, Plc | $31.33 | 2021 | |
| Covidien Lp | $22.49 | 2019 | |
| Sandoz INC. | $22.14 | 2019 | |
| Pharming Healthcare, INC. | $21.29 | 2024 | Ruconest |
| Horizon Therapeutics Plc | $20.54 | 2019 | |
| Circassia INC. | $19.90 | 2020 | |
| Ambu INC. | $18.92 | 2024 | |
| Gilead Sciences, INC. | $18.70 | 2022 | |
| Ani Pharmaceuticals, INC. | $17.80 | 2024 | Purified Cortrophin Gel |
| Monaghan Medical Corporation | $13.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.